ACG

Annual Postgraduate Course
A Practical Approach to Clinical Gastroenterology and Hepatology

October 12-13, 2013Ballroom 6


Program Description:
With the ever-increasing demands to remain abreast of the many new and emerging advancements in the field of gastroenterology and the volume of patients continuing to increase as the population ages, the clinical gastroenterologist is more challenged than ever to deliver the best patient care in each situation they encounter. Research in a multitude of gastroenterology and hepatology areas continues to progress at a rapid pace. The outcome of advances in technology, diagnostic modalities, and therapeutic options has had a positive impact on the management of many GI diseases, and this impact can be expected to grow as we move into the future. Scientific education, based on critical foundational knowledge and clinical skills, the communication of practical methods for treatment, and the ability to integrate the newest tools in diagnosis with the latest therapeutic/treatment options are key necessities for the GI clinician to deliver top quality patient care. This course will provide updates on a variety of gastroenterology and hepatology subjects including luminal GI conditions, gastrointestinal bleeding, inflammatory bowel disease, Barrett’s esophagus, acute pancreatitis, liver disease, pancreaticobiliary disease, functional GI disorders, and endoscopy. Expert faculty will deliver scientific presentations in a variety of formats. Didactic lectures, followed by interactive question and answer sessions, small group learning luncheons, and a choice of breakout sessions on the latest topics in GI and liver clinical care will be offered.

The program is designed primarily for clinicians in GI/hepatology as well as physician assistants, nurse practitioners and other advanced practice healthcare professionals interested in an aggressive but scientifically sound approach to the management of GI and liver illnesses.

Accreditation:
The American College of Gastroenterology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American College of Gastroenterology designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Co-Directors:
Lin Chang, MD, FACG, and Peter V. Draganov, MD, FACG

Saturday, October 12, 2013
7:50 am – 5:00 pm

7:50 am Introduction by Course Directors

Session 1A: Luminal GI Conditions
Moderator: Lawrence J. Brandt, MD, MACG


8:00 am

New Insights on Gluten Intolerance
Sheila E. Crowe, MD, FACG

  • Elucidate the diagnostic and treatment strategies in celiac disease and gluten intolerance.
8:20 am

Diverticular Disease as a Chronic Illness: Evolving Epidemiologic and Clinical Insights
Brennan M. R. Spiegel, MD, MSHS, FACG

  • Address the epidemiology, pathophysiology, and management of chronic, symptomatic diverticular disease.
8:40 am

Clostridium difficile: New Weapons Against an Old Enemy
Neil H. Stollman, MD, FACG

  • Discuss new approaches in treating Clostridium difficile colitis and improving outcomes.
9:00am

Ischemic Colitis: What Is New?
Lawrence J. Brandt, MD, MACG

  • Review advances in the diagnosis, pathophysiology and treatment of ischemic colitis.
9:20 am

Panel Q & A

9:40 am

Break

10:00 am

The David Sun Lecture
Gastroenterology and Public Health in the Era of Health Reform
Howard K. Koh, MD, MPH, Assistant Secretary for Health, U.S. Department of Health and Human Services

Session 1B: Gastrointestinal Bleeding: Maximizing Outcomes and Minimizing Risks
Moderator: Loren A. Laine, MD, FACG


10:30 am

Obscure Small Bowel Bleeding: Capsules, Balloons, Catheters, and Scanners
John A. Martin, MD

  • Describe the various modalities in detecting the cause and location of obscure small bowel bleeding.
10:50 am

Non-variceal Upper GI Bleeding
Alan N. Barkun, MD, CM, MSc (Clinical Epi.), FACG

  • Provide updates on the role of endoscopy and management approaches for non-variceal upper GI bleeding.
11:10 am

Variceal GI Bleeding
Loren A. Laine, MD, FACG

  • Review new techniques and treatment strategies in controlling variceal GI bleeds.
11:30 am

Lower GI Bleeding
Dean M. Jensen, MD, FACG

  • Review the causes, diagnostic approaches and management of lower GI bleeding.
11:50 am

Panel Q & A

12:10 noon

Break for Learning Luncheons
See ticket for room assignment

12:20 pm – 1:35 pm
Saturday Learning Luncheons

Cost is $75 per person/per lunch. Separate registration required.

  1. Treatment of Refractory GERD and Functional Chest Pain
    Ronnie Fass, MD, FACG
    • Recommend the evaluation and treatment of GERD patients who are unresponsive or partially respond to PPIs and patients with functional chest pain.

  2. Esophageal and Anorectal Manometry: When to Order, How Does It Help in Patient Management?
    Jeffrey L. Conklin, MD, FACG
    • Characterize the utility of esophageal and anorectal manometry in the evaluation of common GI symptoms.

  3. Current Management of Fecal Incontinence
    Satish S. C. Rao, MD, PhD, FACG
    • Review the current management of fecal incontinence including newer treatment interventions.

  4. Optimizing Colonoscopy Skills, Polyp Detection and Bowel Preparation
    Douglas K. Rex, MD, MACG
    • Discuss techniques to improve colonoscopy outcomes.

  5. The Use of Electrosurgical Equipment for the Practicing Gastroenterologist
    Priya Jamidar, MD, FACG
    • Provide understanding of the electrosurgical equipment principles, safety and applications in endoscopy.

  6. Management of Chronic Abdominal Pain
    Douglas A. Drossman, MD, MACG
    • Discuss the multidimensional approach in managing patients with chronic abdominal pain.

  7. Medico-legal Aspects of ERCP
    Peter B. Cotton, MD, FACG
    • Discuss strategies to decrease the risk of litigation related to the practice of ERCP.

  8. What Is New in Diagnostic and Interventional EUS
    Norio Fukami, MD
    • Provide updates on the diagnostic and interventional utility of endoscopic ultrasound in GI disease.

  9. HCV: Treat Now or Wait for IFN-free
    David R. Nelson, MD, FACG
    • Facilitate selection of the optimal time to initiate therapy for hepatitis C in an environment of rapidly evolving therapeutic choices.

  10. Evaluation and Treatment of Ascites
    David G. Koch, MD, MSCR
    • Discuss the diagnostic evaluation and treatment of ascites.

  11. Pancreatic Cysts
    Jonathan M. Buscaglia, MD
    • Discuss the diagnostic options for the evaluation of pancreatic cysts and the new International Association of Pancreatology management guidelines.

  12. The Inpatient Consult for Elevated Liver Enzymes
    Norah A. Terrault, MD, MPH, FACG
    • Discuss the assessment of elevated liver function tests in hospitalized patients.

Session 1C: Advances in Inflammatory Bowel Disease
Moderator: David T. Rubin, MD, FACG


1:45 pm

Cancer Screening in IBD
David T. Rubin, MD, FACG

  • Provide guidance on cancer screening in patients with inflammatory bowel disease and the management of dysplasia-associated lesions or masses (DALMs) and sporadic adenomas.
2:05 pm

Perianal Disease in Crohn’s Disease
David A. Schwartz, MD, FACG

  • Review the assessment and treatment of perianal disease in patients with Crohn’s disease.
2:25 pm Optimal Use of Immunomodulators and Biologics
Edward V. Loftus, Jr., MD, FACG
  • Discuss how to optimize the use of immunomodulators and biologic therapies in the treatment of inflammatory bowel disease.
2:45 pm New Therapeutic Agents in IBD
William J. Sandborn, MD, FACG
  • Review the novel therapeutic agents for the treatment of inflammatory bowel disease.
3:05 pm

Panel Q & A

3:25 pm

Break

3:45 pm – 5:00 pm
Simultaneous Sessions

Symposium A: Endoscopic Therapies for Barrett’s Esophagus with High Grade Dysplasia (HGD) or Early Cancer: A Multitude of Choices
Moderator: Michael B. Wallace, MD, MPH, FACG


3:45 pm The Role of Ablation
Kenneth K. Wang, MD, FACG
  • Describe the available options for ablative therapy and facilitate the choice of ablative therapy in Barrett’s esophagus with HGD or early cancer.
4:05 pm The Role of Endoscopic Mucosal Resection (EMR)
Michael B. Wallace, MD, MPH, FACG
  • Describe the role of EMR for the therapy of Barrett’s esophagus with HGD or early cancer.
4:25 pm The Role of Endoscopic Submucosal Dissection (ESD)
Norio Fukami, MD
  • Describe the role of ESD for the therapy of Barrett’s esophagus with HGD or early cancer.
4:45 pm

Panel Q & A

Symposium B: Multidisciplinary Approach to Acute Pancreatitis
Moderator: Timothy B. Gardner, MD, FACG


3:45 pm Medical Management of Acute Pancreatitis
Timothy B. Gardner, MD, FACG
  • Discuss medical interventions and their timing in the management of acute pancreatitis.
4:05 pm Endoscopic Management of Acute Pancreatitis
Stuart Sherman, MD, FACG
  • Discuss endoscopic interventions in the management of acute pancreatitis.
4:25 pm Surgical Management of Acute Pancreatitis
Steven J. Hughes, MD
  • Discuss surgical options in the management of acute pancreatitis.
4:45 pm

Panel Q & A

Symposium C: Cholestatic Liver Disease
Moderator: Adrian Reuben, MBBS, FACG


3:45 pm

Drug Induced Cholestasis
Adrian Reuben, MBBS, FACG

  • Discuss drug induced cholestasis in the differential diagnosis of cholestatic liver disease.
4:05 pm

PBC and PSC
Keith D. Lindor, MD, FACG

  • Provide an update of the recent developments in the diagnosis and management of PBC and PSC.
4:25 pm Cholestatic Autoimmune Hepatitis and Overlap Syndromes
Albert J. Czaja, MD, FACG
  • Discuss cholestatic autoimmune hepatitis in the differential diagnosis of cholestatic liver disease and facilitate therapeutic choices.
4:45 pm

Panel Q & A

Sunday, October 13, 2013
7:50 am – 5:00 pm


7:50 am Introduction by Course Directors

Session 2A: GI Endoscopy
Moderator: Peter V. Draganov, MD, FACG


8:00 am Approach to Subepithelial Lesions
Jonathan M. Buscaglia, MD
  • Provide an overview of the types of subepithelial lesions, diagnostic evaluation and management algorithm.
8:20 am

Preventing Post-ERCP Pancreatitis: Have We Found the Magic Bullet?
Peter V. Draganov, MD, FACG

  • Outline the risk factors for post-ERCP pancreatitis and provide strategies for prophylaxis.
8:40 am

Sedation for Endoscopy: What Does the Future Hold?
John J. Vargo, II, MD, MPH, FACG

  • Outline the choices for sedation at the time of endoscopy and discuss the current legislative landscape.
9:00 am

The New Colonoscopy Surveillance Guidelines
David A. Lieberman, MD, FACG

  • Review the latest consensus guidelines on surveillance colonoscopy.
9:20 am

Panel Q & A

9:40 am

Break

Session 2B: Liver Disease
Moderator: David R. Nelson, MD, FACG


10:00 am Changing Treatment Paradigms for HCV

David R. Nelson, MD, FACG

  • Discuss the current choices for therapy of HCV.
10:20 am The Risks of Surgery in Patients with Liver Disease
Joseph K. Lim, MD, FACG
  • Facilitate the evaluation and risk stratification of patients with liver disease in need of possible surgery.
10:40 am Liver Disease in Pregnancy
Mary E. Rinella, MD, FACG
  • Discuss liver diseases in pregnancy.
11:00 am

Hepatic Encephalopathy
Fred Poordad, MD

  • Discuss the diagnostic evaluation and current management strategies of patients with hepatic encephalopathy.
11:20 am

Alcoholic Hepatitis
David G. Koch, MD

  • Discuss current management strategies of patients with alcoholic hepatitis.
11:40 am

Panel Q & A

12:00 noon

Break for Learning Luncheons
See ticket for room assignment

12:20 pm – 1:35 pm
Sunday Learning Luncheons

Cost is $75 per person/per lunch. Separate registration required.

  1. Optimal Polypectomy Technique: The Search Continues
    Gregory G. Ginsberg, MD, FACG
    • Facilitate the choice of optimal polypectomy technique.

  2. The Changing Face of Helicobacter pylori
    William D. Chey, MD, FACG
    • Summarize the current approach in detecting Helicobacter pylori before and after treatment and the recommended treatment regimens.

  3. Management of Refractory Constipation
    Satish S. C. Rao, MD, PhD, FACG
    • Review diagnostic testing and treatment in patients with chronic constipation who do not respond to traditional treatments.

  4. Advanced Endoscopic Imaging Techniques: Making the Endoscopist Work Smarter and Not Longer
    Kenneth K. Wang, MD, FACG
    • Discuss advanced endoscopic imaging techniques and their application in everyday practice.

  5. The Pregnant Patient with IBD
    Sunanda V. Kane, MD, MSPH, FACG
    • Describe the management approach in pregnant patients with inflammatory bowel disease.

  6. Eosinophilic Esophagitis: Guidance on Diagnosis and Treatment
    Nicholas J. Shaheen, MD, MSPH, FACG
    • Discuss updates on the diagnosis and treatment of eosinophilic esophagitis.

  7. Therapy for Hepatitis C: How to Minimize and Manage Side Effects
    Fred Poordad, MD
    • Provide management strategies to minimize and manage side effects from HCV targeted therapy.

  8. Non-alcoholic Fatty Liver Disease
    Mary E. Rinella, MD, FACG
    • Discuss recent developments in the diagnosis and therapy of NAFLD.

  9. Meaningful Interventions in Chronic Pancreatitis: When to Endoscope, When to Drain and When to Transplant
    Timothy B. Gardner, MD, FACG and Steven Hughes, MD
    • Discuss current strategies for prophylaxis of post-ERCP pancreatitis and facilitate the choice of an appropriate strategy.

  10. Evidence-based Medicine for the Practicing Gastroenterologist
    Paul Moayyedi, MB, ChB, PhD, FACG
    • Provide information on how to interpret and understand the value and clinical relevance of evidence-based medicine.

  11. Colorectal Cancer Screening: Medico-legal Issues
    Douglas G. Adler, MD, FACG
    • Explore common issues in colorectal cancer screening that lead to malpractice claims and identify strategies to minimize liability.

  12. Capsule Endoscopy: Current Indications and Future Innovations
    Jonathan A. Leighton, MD, FACG
    • Review the recommended indications for capsule endoscopy as well as future directions in its diagnostic uses.

Session 2C: Pancreaticobiliary Disease
Moderator: Peter B. Cotton, MD, FACG


1:45 pm

The Current State of ERCP: Where We Are and Where We Go
Peter B. Cotton, MD, FACG

  • Discuss quality improvement strategies and safety in the practice of ERCP.
2:05 pm

Chronic Pancreatitis: New Insights in Etiology
Michelle A. Anderson, MD, MSc

  • Discuss recent developments in our understanding of the etiology of chronic pancreatitis.
2:25 pm

Chronic Pancreatitis: When to Scope?
Gregory A. Coté, MD, MS

  • Discuss endoscopy based therapy for chronic pancreatitis and provide guidance on when to choose endoscopic therapy.
2:45 pm

Chronic Pancreatitis: When to Operate?
Steven J. Hughes, MD

  • Discuss surgical therapy for chronic pancreatitis and provide guidance on when to choose surgery.
3:05 pm

Panel Q & A

3:25 pm

Break

3:30 pm – 7:00 pm Exhibit Hall Opens
Exhibit Halls A-C
3:30 pm – 7:00 pm Poster Sessions
Exhibit Halls A-C
3:30 pm – 7:00 pm Hands-on Workshop Center
Exhibit Halls A-C, Booth #2113

3:45 pm - 5:00 pm
Simultaneous Sessions

Symposium D: Optimizing Management of Functional Gastrointestinal Disorders
Moderator: William D. Chey, MD, FACG


3:45 pm Gastroparesis: Optimizing Management and Improving Outcomes
Henry P. Parkman, MD, FACG
  • Discuss clinical symptoms, diagnosis and treatment approach in gastroparesis.
4:05 pm

Bloating: Blowing Up the Old Myths on a Common Problem
William D. Chey, MD, FACG

  • Review the mechanisms underlying bloating and distension, and the current and emerging therapeutic approaches to effectively manage these symptoms.
4:25 pm Differentiating and Treating IBS-C and Chronic Constipation
Lin Chang, MD, FACG
  • Discuss how to diagnose and differentiate irritable bowel syndrome with constipation and chronic constipation and how this affects treatment.
4:45 pm

Panel Q&A

Symposium E: Individualized Management in IBD
Moderator: Sunanda V. Kane, MD, MSPH, FACG


3:45 pm

Beyond Top-down/Top-up Controversy: How to Stratify Risk in IBD and Choose Tailored Therapy
Stephen B. Hanauer, MD, FACG

  • Discuss predictors of poor outcome in IBD patients and facilitate the choice of therapy based on these predictors.
4:05 pm

Therapeutic Monitoring Optimizes Outcomes in IBD
Sunanda V. Kane, MD, MSPH, FACG

  • Review recommendations regarding the utility of serologic tests and drug level monitoring in patients with inflammatory bowel disease.
4:25 pm

Dietary Intervention and Probiotics in IBD
Donald R. Duerksen, MD

  • Discuss dietary intervention and the use of probiotics in the treatment of inflammatory bowel disease.
4:45 pm

Panel Q & A

Symposium F: Endoscopy in the Obese Patient
Moderator: Gregory G. Ginsberg, MD, FACG


3:45 pm

Endoscopic Management of Bariatric Surgery Complications
John A. Martin, MD

  • Discuss current endoscopy based options in the management of post-bariatric surgery complications.
4:05 pm

ERCP in Patients with Altered Gastric Anatomy
Mihir S. Wagh, MD

  • Discuss management strategies in patients with altered gastric anatomy in need of ERCP.
4:25 pm

Endoscopic Therapies for Obesity: Where We Are and Where We Go
Gregory G. Ginsberg, MD, FACG

  • Discuss current and future endoscopy based therapy for obesity.
4:45 pm

Panel Q & A

5:00 pm Postgraduate Course Adjourns